Jyoti D Patel

Jyoti D Patel

UNVERIFIED PROFILE

Are you Jyoti D Patel?   Register this Author

Register author
Jyoti D Patel

Jyoti D Patel

Publications by authors named "Jyoti D Patel"

Are you Jyoti D Patel?   Register this Author

72Publications

2054Reads

38Profile Views

Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy.

Clin Lung Cancer 2019 Aug 26. Epub 2019 Aug 26.

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; AstraZeneca, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.08.002DOI Listing
August 2019

Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non-Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care.

Clin Lung Cancer 2018 11 26;19(6):e823-e830. Epub 2018 May 26.

Oncology at Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.05.013DOI Listing
November 2018

Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.

J Clin Oncol 2018 10 16;36(28):2863-2871. Epub 2018 Aug 16.

Vasiliki Panou and Oluf D. Røe, Aalborg University Hospital, Aalborg, Denmark; Meghana Gadiraju, Arthur Wolin, Caroline M. Weipert, Emily Skarda, Aliya N. Husain, Jyoti D. Patel, Buerkley Rose, Shannon R. Zhang, Madison Weatherly, Viswateja Nelakuditi, Amy Knight Johnson, Maria Helgeson, David Fischer, Arpita Desai, Nanna Sulai, Lauren Ritterhouse, Kiran K. Turaga, Dezheng Huo, Jeremy Segal, Sabah Kadri, Zejuan Li, Hedy L. Kindler, and Jane E. Churpek, The University of Chicago, Chicago, IL; Oluf D. Røe, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger; and Oluf D. Røe, Norwegian University of Science and Technology, Trondheim, Norway.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.5204
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.5204DOI Listing
October 2018

Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?

Cancer 2018 07 15;124(14):2878-2880. Epub 2018 Jun 15.

Department of Radiation Oncology, The University of Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31557DOI Listing
July 2018

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

J Clin Oncol 2018 06 13;36(16):1611-1618. Epub 2018 Feb 13.

Jason J. Luke, Jeffrey M. Lemons, Theodore G. Karrison, Sean P. Pitroda, James M. Melotek, Yuanyuan Zha, Hania A. Al-Hallaq, Ainhoa Arina, Nikolai N. Khodarev, Linda Janisch, Paul Chang, Jyoti D. Patel, Gini F. Fleming, John Moroney, Manish R. Sharma, Mark J. Ratain, Thomas F. Gajewski, Ralph R. Weichselbaum, and Steven J. Chmura, The University of Chicago, Chicago, IL; Julia R. White, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978468PMC
June 2018

Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.

Clin Lung Cancer 2018 05 5;19(3):230-238.e2. Epub 2017 Dec 5.

Department of Medicine, University of Chicago Medicine and Biological Sciences, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.11.010DOI Listing
May 2018

American Society of Clinical Oncology Strategic Plan for Increasing Racial and Ethnic Diversity in the Oncology Workforce.

J Clin Oncol 2017 Aug 1;35(22):2576-2579. Epub 2017 May 1.

Karen M. Winkfield, Wake Forest Baptist Medical Center, Winston-Salem, NC; Christopher R. Flowers, Winship Cancer Institute, Emory University; Otis W. Brawley, American Cancer Society, Atlanta, GA; Jyoti D. Patel, University of Chicago, Chicago; Patricia Robinson, Loyola University Medical Center, Maywood, IL; Gladys Rodriguez, South Texas Oncology and Hematology, San Antonio, TX; Amit Agarwal, University of Arizona, Tucson, AZ; Lori Pierce and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; Edith P. Mitchell, Thomas Jefferson University Hospital, Philadelphia, PA; and Kimberly T. Head-Smith and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.1372DOI Listing
August 2017

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

J Clin Oncol 2017 Aug 13;35(24):2781-2789. Epub 2017 Jun 13.

Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne; Martin Früh, Kantonsspital St Gallen, St Gallen, Switzerland; Scott Gettinger, Yale Cancer Center, New Haven, CT; Melissa L. Johnson, Sarah Cannon Research Institute, Nashville, TN; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; Marina C. Garassino, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Daniel Christoph, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; Chee Keong Toh, National Cancer Centre, Singapore, Singapore; Naiyer A. Rizvi and Jamie E. Chaft, Memorial Sloan Kettering Cancer Center; Jamie E. Chaft, Weill Cornell Medical College, New York, NY; Enric Carcereny Costa, Catalan Institute of Oncology Badalona, Badalona; Luis Paz-Ares, Hospital Universitario Doce de Octubre & IIS i+12, CNIO, Ciberonc and Universidad Complutense, Madrid; Enriqueta Felip, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Jyoti D. Patel, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; Marianna Koczywas, City of Hope, Duarte; Zhengrong Li, Jiaheng Qiu, Marcin Kowanetz, Simonetta Mocci, Geetha Shankar, and Alan Sandler, Genentech, South San Francisco, CA; Cheryl Ho, Vancouver Centre, BC Cancer Agency, Vancouver, British Columbia; Jeffrey Rothenstein, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa; Frances A. Shepherd, Princess Margaret Cancer Centre/University Health Network and University of Toronto, Toronto, Ontario, Canada; Michel van den Heuvel, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; and Takayasu Kurata, Kansai Medical University Hirakata Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562171PMC
August 2017

Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II.

Future Oncol 2016 Dec 8;12(23):2669-2672. Epub 2016 Sep 8.

Department of Neurology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0378DOI Listing
December 2016

Advances in brain metastases presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part I.

Future Oncol 2016 Nov 5;12(22):2535-2538. Epub 2016 Sep 5.

Department of Neurology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0341DOI Listing
November 2016

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.

Am J Clin Oncol 2016 10;39(5):441-7

*Abramson Cancer Center, University of Pennsylvania, Philadelphia †University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA ‡Feinberg School of Medicine, Northwestern University, Chicago, IL §Genentech Inc., South San Francisco, CA ∥Harold C. Simmons Cancer Center, University of Texas Southwestern, Dallas, TX ¶Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000163DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016219PMC
October 2016

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

J Natl Compr Canc Netw 2016 07;14(7):825-36

From The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; City of Hope Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0087DOI Listing
July 2016

Patterns and Predictors of Chemotherapy Use for Resected Non-Small Cell Lung Cancer.

Ann Thorac Surg 2016 Feb 24;101(2):533-40. Epub 2015 Oct 24.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois; Division of Thoracic Surgery, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.08.077DOI Listing
February 2016

Early stage lung cancer detection in systemic sclerosis does not portend survival benefit: a cross sectional study.

PLoS One 2015 17;10(2):e0117829. Epub 2015 Feb 17.

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117829PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331488PMC
January 2016

Overcoming perceived hurdles in lung cancer screening: the low risk of complications of image-guided transthoracic needle biopsy.

Authors:
Jyoti D Patel

J Oncol Pract 2015 May 24;11(3):e360-2. Epub 2015 Mar 24.

Feinberg School of Medicine of Northwestern University, Chicago, IL

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.003699DOI Listing
May 2015

Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

J Clin Oncol 2015 May 13;33(15):1666-73. Epub 2015 Apr 13.

Melissa L. Johnson, Jyoti D. Patel, Eric M. Hart, Bing Bing Weitner, and Alfred W. Rademaker, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL; and Helena A. Yu, Mark G. Kris, and Gregory J. Riely, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/04/13/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.7328
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.7328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881377PMC
May 2015

Non-Small Cell Lung Cancer, Version 6.2015.

J Natl Compr Canc Netw 2015 May;13(5):515-24

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0071DOI Listing
May 2015

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.

J Clin Oncol 2015 Mar 20;33(7):786-809. Epub 2015 Jan 20.

Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/01/16/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.9746
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.9746DOI Listing
March 2015

Quality of life analyses from the randomized, open-label, phase III PointBreak study of pemetrexed-carboplatin-bevacizumab followed by maintenance pemetrexed-bevacizumab versus paclitaxel-carboplatin-bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.

J Thorac Oncol 2015 Feb;10(2):353-9

*Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN; †Feinberg School of Medicine, Northwestern University, Chicago, IL; ‡Ocala Oncology, Ocala, FL and US Oncology Research, Inc., Houston, TX; §David Geffen School of Medicine at UCLA/Translational Research in Oncology-US, Los Angeles, CA; ║Northwest Georgia Oncology Centers, Marietta, GA; ¶Washington University School of Medicine, St. Louis, MO; #Tulsa Cancer Institute, Tulsa, OK; **Eli Lilly and Company, Indianapolis, IN; ††University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA; and ‡‡Rush University Medical Center, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000277DOI Listing
February 2015

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria.

Cancer 2014 Dec 25;120(24):3853-8. Epub 2014 Aug 25.

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28956DOI Listing
December 2014

Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.

Arch Pathol Lab Med 2014 Oct 26;138(10):1353-7. Epub 2014 Feb 26.

From the Department of Pathology (Drs Villa, Yeldandi, and Raparia), the Division of Medical Oncology, and Robert H. Lurie Comprehensive Cancer Center (Drs Johnson and Patel), the Division of Pulmonary, and Critical Care Medicine (Dr Raj); and the Division of Thoracic Surgery, and Robert H. Lurie Comprehensive Cancer Center (Dr DeCamp), Northwestern University Feinberg School of Medicine, Chicago, Illinois; and the Department of Pathology & Genomic Medicine, The Methodist Hospital, Houston, Texas (Dr Cagle).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0376-OADOI Listing
October 2014

Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.

J Natl Cancer Inst 2014 Oct 12;106(10). Epub 2014 Sep 12.

Northwestern University Feinberg School of Medicine, Chicago, IL (JCS, JRT, CBW, KPS, AWR, JDP, ABB, WJG); Center for Business Models in Healthcare, Chicago, IL (JRT, CBW); UCSF Center for Translational and Policy Research on Personalized Medicine, Department of Clinical Pharmacy, University of California, San Francisco, CA (JRT); Department of Pathology, Dartmouth Hitchcock Medical Center and the Audrey and Theodor Geisel School of Medicine, Dartmouth College, Lebanon, NH (GJT); Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL (EAP).* Current affiliation: Spectrum Health Medical Group, Grand Rapids, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176043PMC
October 2014

Reversible nyctalopia and retinopathy in a patient with metastatic cancer treated with anti-heat shock protein 90 therapy.

JAMA Ophthalmol 2014 Jul;132(7):899-901

Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaophthalmol.2014.409DOI Listing
July 2014

Optimal first-line and maintenance treatments for advanced-stage nonsquamous non-small cell lung cancer.

J Natl Compr Canc Netw 2014 Jun;12(6):889-97

From the Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0083DOI Listing
June 2014

Chemotherapy and targeted therapeutics as maintenance of response in advanced non-small cell lung cancer.

Semin Oncol 2014 Feb 12;41(1):93-100. Epub 2013 Dec 12.

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.12.007DOI Listing
February 2014

Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

J Clin Oncol 2014 Jan 10;32(2):129-60. Epub 2013 Dec 10.

Jyoti D. Patel, Northwestern University; Blasé Polite, University of Chicago Medicine, Chicago, IL; Lada Krilov, American Society of Clinical Oncology, Alexandria, VA; Sylvia Adams and William L. Carroll, New York University Cancer Institute; Carol Aghajanian, Mark G. Kris, and Gary K. Schwartz, Memorial Sloan-Kettering Cancer Center, New York, NY; Ethan Basch, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Marcos de Lima and Mark R. Gilbert, University of Texas MD Anderson Cancer Center, Houston; Ian Thompson, University of Texas Health Science Center at San Antonio, San Antonio, TX; John L. Marshall, Lombardi Cancer Center, Washington, DC; Gregory A. Masters, Helen F. Graham Cancer Center, Newark, DE; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Sunil Sharma, Huntsman Cancer Institute, Salt Lake City, UT; Nicholas J. Vogelzang, US Oncology Research, Comprehensive Cancer Centers of Nevada, Henderson, NV; and Bruce J. Roth, Washington University in St Louis, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.7076DOI Listing
January 2014

Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.

Ther Adv Med Oncol 2014 Jan;6(1):4-15

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, 676 North St. Clair, Suite 850. Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834013510589DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866994PMC
January 2014

Bevacizumab in advanced NSCLC: chemotherapy partners and duration of use.

Curr Treat Options Oncol 2013 Dec;14(4):595-609

Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 676 North St. Clair, Suite 850, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0255-3DOI Listing
December 2013

PointBreak: a randomized phase III study of pemetrexed plus carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab versus paclitaxel plus carboplatin and bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.

J Clin Oncol 2013 Dec 21;31(34):4349-57. Epub 2013 Oct 21.

Jyoti D. Patel, Northwestern University; Philip Bonomi, Rush University Medical Center, Chicago, IL; Mark A. Socinski, University of Pittsburgh, Pittsburgh, PA; Edward B. Garon, University of California at Los Angeles, Los Angeles, CA; Craig H. Reynolds, US Oncology Research, Ocala, FL; David R. Spigel, Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN; Mark R. Olsen, Tulsa Cancer Institute, Tulsa, OK; Robert C. Hermann, Northwest Georgia Oncology Centers, Marietta, GA; Robert M. Jotte, Rocky Mountain Cancer Centers, Denver, CO; Thaddeus Beck, Highlands Oncology Group, Fayetteville, AR; Donald A. Richards, US Oncology Research, Tyler, TX; Susan C. Guba, Jingyi Liu, Bente Frimodt-Moller, and William J. John, Eli Lilly, Indianapolis, IN; Coleman K. Obasaju and Eduardo J. Pennella, Lilly USA, Indianapolis, IN; and Ramaswamy Govindan, Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.9626DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881367PMC
December 2013

Molecular profiling in non-small cell lung cancer: a step toward personalized medicine.

Arch Pathol Lab Med 2013 Apr;137(4):481-91

Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/abs/10.5858/arpa.2012
Publisher Site
http://dx.doi.org/10.5858/arpa.2012-0287-RADOI Listing
April 2013

Role of American Society of Clinical Oncology in low- and middle-income countries.

J Clin Oncol 2011 Aug 27;29(22):3097-102. Epub 2011 Jun 27.

MSc, FRCS(C), 20 York St, Breast Center, 1st Floor, Suite A, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2011/06/27/JCO.2011.35
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2011.35.6378
Publisher Site
http://dx.doi.org/10.1200/JCO.2011.35.6378DOI Listing
August 2011

Emerging concepts in the pathology and molecular biology of advanced non-small cell lung cancer.

Am J Clin Pathol 2011 Aug;136(2):228-38

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/ajcp/article-lookup/doi/10.1309/AJC
Publisher Site
http://dx.doi.org/10.1309/AJCPO66OIRULFNLZDOI Listing
August 2011

Sex differences in susceptibility to carcinogens.

Semin Oncol 2009 Dec;36(6):516-23

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.09.005DOI Listing
December 2009

Lung cancer: a biologically different disease in women?

Authors:
Jyoti D Patel

Womens Health (Lond) 2009 Nov;5(6):685-91

Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, 676 N St Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.09.66DOI Listing
November 2009

Improving health-related quality of life in non-small-cell lung cancer with current treatment options.

Clin Lung Cancer 2008 Jul;9(4):206-12

Evanston Northwestern Healthcare, Evanston, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.030DOI Listing
July 2008

Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.

J Clin Oncol 2008 Mar;26(9):1472-8

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Howard Building, Room 1012, 1275 York Ave, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.13.0062DOI Listing
March 2008

Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.

Authors:
Jyoti D Patel

Curr Opin Oncol 2006 Nov;18(6):609-14

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cco.0000245308.67144.d2DOI Listing
November 2006

Combination treatment of vertebral metastases using image-guided percutaneous radiofrequency ablation and vertebroplasty: a case report.

Surg Neurol 2005 May;63(5):469-74; discussion 474-5

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009030190400526
Publisher Site
http://dx.doi.org/10.1016/j.surneu.2004.04.025DOI Listing
May 2005

Lung cancer in women.

Authors:
Jyoti D Patel

J Clin Oncol 2005 May;23(14):3212-8

Division of Hematology/Oncology, Northwestern University, 676 N St Clair Street, Suite 850, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.11.486DOI Listing
May 2005

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of bronchoalveolar carcinoma.

Authors:
Jyoti D Patel

Clin Lung Cancer 2004 Dec;6 Suppl 1:S43-7

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
December 2004

Induction chemotherapy for resectable non-small-cell lung cancer.

Oncology (Williston Park) 2004 Nov;18(13):1591-602; discussion 1602-3, 1606, 1611-2

Department of Medicine, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
November 2004

Pemetrexed: a novel antifolate agent enters clinical practice.

Expert Rev Anticancer Ther 2004 Aug;4(4):511-22

Department of Medicine, Division of Hematology/Oncology, The Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.4.4.511DOI Listing
August 2004

Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.

Crit Rev Oncol Hematol 2004 Jun;50(3):175-86

Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2004.02.004DOI Listing
June 2004

Lung cancer in US women: a contemporary epidemic.

JAMA 2004 Apr;291(14):1763-8

Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Ill 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.291.14.1763DOI Listing
April 2004

Targeting lethal minimal residual disease in small cell lung cancer.

Semin Oncol 2003 Feb;30(1):79-85

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.50018DOI Listing
February 2003